Sign in to view content

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?

Susan B. Bressler, MD, FASRS

Video
Published 2018

Related

My Practice is Worth WHAT? Equity Acquisition in the Retina World
Robert L. Avery, MD
Carl W. Baker, MD, FASRS
Michael S. Jacobson, MD
Reginald J. Sanders, MD, FASRS
Annual Meeting Talks
2018
Comparison of Visual and Anatomic Results After Combined Boston Keratoprosthesis, Vitrectomy and Glaucoma Surgery (as Needed) to Keratoprosthesis Alone
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2018
Imaging Signatures and Cytokine Expression in Diabetic Macular Edema From the IMAGINE Study: Biomarker Exploration for Precision Medicine
Sruthi Arepalli, MD
On Demand Cases, Courses, and Papers
2020

Category: Diabetic Retinopathy

See more